iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Total Liabilities (Quarterly) : 129.28M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | 129.28M |
| March 31, 2025 | 95.45M |
| December 31, 2024 | 96.68M |
| September 30, 2024 | 91.38M |
| June 30, 2024 | 87.97M |
| March 31, 2024 | 88.57M |
| December 31, 2023 | 92.36M |
| September 30, 2023 | 79.38M |
| June 30, 2023 | 80.22M |
| March 31, 2023 | 76.08M |
| December 31, 2022 | 91.66M |
| Date | Value |
|---|---|
| September 30, 2022 | 143.67M |
| June 30, 2022 | 177.47M |
| March 31, 2022 | 223.94M |
| December 31, 2021 | 331.89M |
| September 30, 2021 | 550.34M |
| June 30, 2021 | 29.19M |
| March 31, 2021 | 20.28M |
| December 31, 2020 | 21.36M |
| September 30, 2020 | 15.32M |
| June 30, 2020 | 12.16M |
| March 31, 2020 | 14.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ZimVie, Inc. (DELISTED) | 345.42M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Black Titan Corp. | 2.65M |
| Solid Biosciences, Inc. | 46.50M |
| Replimune Group, Inc. | 146.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 623.08M |
| Shareholders Equity (Quarterly) | 493.80M |
| Debt to Equity Ratio | 0.0104 |
| Current Ratio | 7.528 |
| Net Debt Paydown Yield | 0.03% |